Skip to main content
Top
Published in: Trials 1/2010

Open Access 01-12-2010 | Study protocol

A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study

Authors: Charity D Evans, Dean T Eurich, Jeff G Taylor, Alfred J Remillard, Yvonne M Shevchuk, David F Blackburn

Published in: Trials | Issue 1/2010

Login to get access

Abstract

Background

Traditional randomized controlled trials are considered the gold standard for evaluating the efficacy of a treatment. However, in adherence research, limitations to this study design exist, especially when evaluating real-world applicability of an intervention. Although adherence interventions by community pharmacists have been tested, problems with internal and external validity have limited the usefulness of these studies, and further well-designed and well-conducted research is needed. We aimed to determine the real-world effectiveness of a community pharmacy adherence intervention using a robust study design. This novel design integrates cluster randomization and an outcome evaluation of medication adherence using a population-based administrative data source in the province of Saskatchewan, Canada.

Methods/Design

Community pharmacies from across the province of Saskatchewan, Canada were randomized to deliver an adherence intervention to their patients or usual care. Intervention pharmacies were trained to employ a practical adherence strategy targeted at new users of statin medications. While randomization and implementation of the intervention occurred at the community pharmacy level, the outcome analysis will occur at the level of the individual subjects. The primary outcome is the mean statin adherence among all eligible new users of statin medications. Secondary outcomes include the proportion of new statin users who exhibit adherence ≥80%, and persistence with statin use.

Discussion

This novel study design was developed to combine the rigor of a randomized trial with a pragmatic approach to implementing and capturing the results in a real-world fashion. We believe this approach can serve as an example for future study designs evaluating practice-based adherence interventions.

Trial Registration

ClinicalTrials.gov no. NCT00971412.
Literature
1.
go back to reference Moher D, Jadad A, Nichol G, Penman M, Tugwell P, Walsh S: Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Controlled Clinical Trials. 1995, 16: 62-73. 10.1016/0197-2456(94)00031-W.CrossRefPubMed Moher D, Jadad A, Nichol G, Penman M, Tugwell P, Walsh S: Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Controlled Clinical Trials. 1995, 16: 62-73. 10.1016/0197-2456(94)00031-W.CrossRefPubMed
2.
go back to reference McDonald H, Garg A, Haynes RB: Interventions to enhance patient adherence to medication prescriptions. JAMA. 2002, 288: 2868-2879. 10.1001/jama.288.22.2868.CrossRefPubMed McDonald H, Garg A, Haynes RB: Interventions to enhance patient adherence to medication prescriptions. JAMA. 2002, 288: 2868-2879. 10.1001/jama.288.22.2868.CrossRefPubMed
3.
go back to reference Van Wijk B, Klungel O, Heerdink E, de Boer A: Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother. 2005, 39: 319-328. 10.1345/aph.1E027.CrossRefPubMed Van Wijk B, Klungel O, Heerdink E, de Boer A: Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother. 2005, 39: 319-328. 10.1345/aph.1E027.CrossRefPubMed
4.
go back to reference Bouvy M, Heerdink E, Urquart J, Grobbee D, Hoe A, Leufkens H: Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Failure. 2003, 9: 404-411. 10.1054/S1071-9164(03)00130-1.CrossRef Bouvy M, Heerdink E, Urquart J, Grobbee D, Hoe A, Leufkens H: Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Failure. 2003, 9: 404-411. 10.1054/S1071-9164(03)00130-1.CrossRef
5.
go back to reference Park J, Kelly P, Carter B, Burgess P: Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc. 1996, NS36: 443-451.CrossRef Park J, Kelly P, Carter B, Burgess P: Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc. 1996, NS36: 443-451.CrossRef
6.
go back to reference Lee L, Grace K, Taylor A: Effect of a pharmacy care program on medication adherence and persistence blood pressure and low-density lipoprotein cholesterol. A randomized controlled trial. JAMA. 2006, 296: 2563-2571. 10.1001/jama.296.21.joc60162.CrossRefPubMed Lee L, Grace K, Taylor A: Effect of a pharmacy care program on medication adherence and persistence blood pressure and low-density lipoprotein cholesterol. A randomized controlled trial. JAMA. 2006, 296: 2563-2571. 10.1001/jama.296.21.joc60162.CrossRefPubMed
7.
go back to reference Charrois T, Durec T, Tsuyuki R: Systematic reviews of pharmacy practice research: methodological issues in searching evaluating, interpreting and disseminating results. Ann Pharmacother. 2009, 43: 118-122. 10.1345/aph.1L302.CrossRefPubMed Charrois T, Durec T, Tsuyuki R: Systematic reviews of pharmacy practice research: methodological issues in searching evaluating, interpreting and disseminating results. Ann Pharmacother. 2009, 43: 118-122. 10.1345/aph.1L302.CrossRefPubMed
8.
go back to reference Simpson S, Johnson J, Biggs C, Biggs R, Kuntz A, Semchuk W, Taylor J, Farris K, Tsuyuki R: Practice-based research: lessons from community pharmacist participants. Pharmacotherapy. 2001, 21: 731-739. 10.1592/phco.21.7.731.34570.CrossRefPubMed Simpson S, Johnson J, Biggs C, Biggs R, Kuntz A, Semchuk W, Taylor J, Farris K, Tsuyuki R: Practice-based research: lessons from community pharmacist participants. Pharmacotherapy. 2001, 21: 731-739. 10.1592/phco.21.7.731.34570.CrossRefPubMed
9.
go back to reference Farris K, Schopflocher D: Between intention and behaviour: an application of community pharmacists' assessment of pharmaceutical care. Social Science & Medicine. 1999, 49: 55-66.CrossRef Farris K, Schopflocher D: Between intention and behaviour: an application of community pharmacists' assessment of pharmaceutical care. Social Science & Medicine. 1999, 49: 55-66.CrossRef
10.
go back to reference Armour C, Brillant M, Krass I: Pharmacists' views on involvement in pharmacy practice research: strategies for facilitating participation. Pharmacy Practice. 2007, 5: 59-66.CrossRefPubMedPubMedCentral Armour C, Brillant M, Krass I: Pharmacists' views on involvement in pharmacy practice research: strategies for facilitating participation. Pharmacy Practice. 2007, 5: 59-66.CrossRefPubMedPubMedCentral
11.
go back to reference Saini B, Brillant M, Filipovska J, Gelgor L, Mitchell B, Rose G, Smith L: Factors influencing Australian community pharmacists' willingness to participate in research projects - an exploratory study. Int J Pharm Pract. 2006, 14: 179-188. 10.1211/ijpp.14.3.0004.CrossRef Saini B, Brillant M, Filipovska J, Gelgor L, Mitchell B, Rose G, Smith L: Factors influencing Australian community pharmacists' willingness to participate in research projects - an exploratory study. Int J Pharm Pract. 2006, 14: 179-188. 10.1211/ijpp.14.3.0004.CrossRef
12.
go back to reference Blackburn D, Dobson R, Blackburn J, Wilson T, Stang MR, Semchuk W: Adherence to statins beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: A retrospective cohort study. Can J Cardiol. 2005, 21: 485-488.PubMed Blackburn D, Dobson R, Blackburn J, Wilson T, Stang MR, Semchuk W: Adherence to statins beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: A retrospective cohort study. Can J Cardiol. 2005, 21: 485-488.PubMed
13.
go back to reference Jackevicius C, Mamdani M, Tu J: Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002, 288: 462-467. 10.1001/jama.288.4.462.CrossRefPubMed Jackevicius C, Mamdani M, Tu J: Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002, 288: 462-467. 10.1001/jama.288.4.462.CrossRefPubMed
14.
go back to reference Pedan A, Laleh V, Schneeweiss S: Analysis of factors associated with statin adherence in a hierarchical model considering physician pharmacy, patient and prescription characteristics. J Manag Care Pharm. 2007, 13: 487-496.PubMed Pedan A, Laleh V, Schneeweiss S: Analysis of factors associated with statin adherence in a hierarchical model considering physician pharmacy, patient and prescription characteristics. J Manag Care Pharm. 2007, 13: 487-496.PubMed
15.
go back to reference Lamb D, Eurich D, McAlister F, Tsuyuki R, Semchuk W, Wilson T, Blackburn D: Changes in adherence to evidence-based medications in the first year after intial hospitalization for heart failure. Observational cohort study from 1994-2003. Circ Cardiovasc Qual Outcomes. 2009, 2: 228-235. 10.1161/CIRCOUTCOMES.108.813600.CrossRefPubMed Lamb D, Eurich D, McAlister F, Tsuyuki R, Semchuk W, Wilson T, Blackburn D: Changes in adherence to evidence-based medications in the first year after intial hospitalization for heart failure. Observational cohort study from 1994-2003. Circ Cardiovasc Qual Outcomes. 2009, 2: 228-235. 10.1161/CIRCOUTCOMES.108.813600.CrossRefPubMed
16.
go back to reference McAlister F, Eurich D, Majumdar S, Johnson J: The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy. Eur J Heart Failure. 2008, 10: 703-708. 10.1016/j.ejheart.2008.05.013.CrossRef McAlister F, Eurich D, Majumdar S, Johnson J: The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy. Eur J Heart Failure. 2008, 10: 703-708. 10.1016/j.ejheart.2008.05.013.CrossRef
17.
go back to reference Blackburn D, Dobson R, Blackburn J, Wilson T: Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy. 2005, 25: 1035-1043. 10.1592/phco.2005.25.8.1035.CrossRefPubMed Blackburn D, Dobson R, Blackburn J, Wilson T: Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy. 2005, 25: 1035-1043. 10.1592/phco.2005.25.8.1035.CrossRefPubMed
18.
go back to reference Downey W, Stang MR, Beck P, Osei W, Nichol J: Health Services Databases in Saskatchewan. Pharamcoepidemiology. Edited by: Strom B. 2005, Philadelphia: John Wiley & Sons Ltd, 4 Downey W, Stang MR, Beck P, Osei W, Nichol J: Health Services Databases in Saskatchewan. Pharamcoepidemiology. Edited by: Strom B. 2005, Philadelphia: John Wiley & Sons Ltd, 4
19.
go back to reference Karve S, Cleves M, Helm M, Hudson T, West D, Martin B: An Empirical Basis for Standardizing Adherence Measures Derived From Administrative Claims Data Among Diabetic Patients. Med Care. 2008, 46: 1125-1133. 10.1097/MLR.0b013e31817924d2.CrossRefPubMed Karve S, Cleves M, Helm M, Hudson T, West D, Martin B: An Empirical Basis for Standardizing Adherence Measures Derived From Administrative Claims Data Among Diabetic Patients. Med Care. 2008, 46: 1125-1133. 10.1097/MLR.0b013e31817924d2.CrossRefPubMed
20.
go back to reference Ho M, Magid D, Shetterly S, Olson K, Maddox T, Peterson P, Masoudi F, Rumsfeld J: Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008, 155: 772-779. 10.1016/j.ahj.2007.12.011.CrossRefPubMed Ho M, Magid D, Shetterly S, Olson K, Maddox T, Peterson P, Masoudi F, Rumsfeld J: Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008, 155: 772-779. 10.1016/j.ahj.2007.12.011.CrossRefPubMed
21.
go back to reference Evans C, Eurich D, Lamb D, Taylor J, Jorgenson D, Semchuk W, Mansell K, Blackburn D: Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada. JMCP. 2009, 15: 476-484.CrossRefPubMed Evans C, Eurich D, Lamb D, Taylor J, Jorgenson D, Semchuk W, Mansell K, Blackburn D: Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada. JMCP. 2009, 15: 476-484.CrossRefPubMed
22.
go back to reference Larsen J, Andersen M, Kragstrup J, Gram L: High persistence of statin use in a Danish population: Compliance study 1993-1998. Br J Clin Pharmacol. 2002, 53: 375-378. 10.1046/j.1365-2125.2002.01563.x.CrossRefPubMedPubMedCentral Larsen J, Andersen M, Kragstrup J, Gram L: High persistence of statin use in a Danish population: Compliance study 1993-1998. Br J Clin Pharmacol. 2002, 53: 375-378. 10.1046/j.1365-2125.2002.01563.x.CrossRefPubMedPubMedCentral
23.
go back to reference Foody J, Joyce A, Rudolph A, Lui L, Benner J: Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. Curr Med Res Opin. 2005, 24: 1987-2000. 10.1185/03007990802203279.CrossRef Foody J, Joyce A, Rudolph A, Lui L, Benner J: Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. Curr Med Res Opin. 2005, 24: 1987-2000. 10.1185/03007990802203279.CrossRef
24.
go back to reference Smith D, Kramer J, Perrin N, Platt R, Roblin D, Lane K, Goodman M, Nelson W, Yang X, Soumerai S: A randomized trial of direct-to-patient communication to enhance adherence to B-blocker therapy following myocardial infarction. Arch Intern Med. 2008, 168: 477-483. 10.1001/archinternmed.2007.132.CrossRefPubMed Smith D, Kramer J, Perrin N, Platt R, Roblin D, Lane K, Goodman M, Nelson W, Yang X, Soumerai S: A randomized trial of direct-to-patient communication to enhance adherence to B-blocker therapy following myocardial infarction. Arch Intern Med. 2008, 168: 477-483. 10.1001/archinternmed.2007.132.CrossRefPubMed
25.
go back to reference Qureshi A, Suri F, Kirmani J, Divani A: The relative impact of inadequate primary and secondary prevention on cardiovascular mortality in the united states. Stroke. 2004, 35: 2346-2350. 10.1161/01.STR.0000141417.66620.09.CrossRefPubMed Qureshi A, Suri F, Kirmani J, Divani A: The relative impact of inadequate primary and secondary prevention on cardiovascular mortality in the united states. Stroke. 2004, 35: 2346-2350. 10.1161/01.STR.0000141417.66620.09.CrossRefPubMed
26.
go back to reference Hayes R, Moulton L: Regression analysis based on individual-level data. Cluster Randomised Trials. 2009, Boca Raton: Chapman & Hall/CRC, 199-231. full_text.CrossRef Hayes R, Moulton L: Regression analysis based on individual-level data. Cluster Randomised Trials. 2009, Boca Raton: Chapman & Hall/CRC, 199-231. full_text.CrossRef
27.
go back to reference Donner A, Piaggio G, Villar J, Pinol A, al-Mazrou Y, Ba'aqeel H, Bakketeig L, Belizán JM, Berendes H, Carroli G, Farnot U, Lumbiganon P: Methodological considerations in the design of the WHO Antenatal Care Randomised Controlled Trial. Paediatric & Perinatal Epidemiology. 1998, 12: 59-74.CrossRef Donner A, Piaggio G, Villar J, Pinol A, al-Mazrou Y, Ba'aqeel H, Bakketeig L, Belizán JM, Berendes H, Carroli G, Farnot U, Lumbiganon P: Methodological considerations in the design of the WHO Antenatal Care Randomised Controlled Trial. Paediatric & Perinatal Epidemiology. 1998, 12: 59-74.CrossRef
29.
30.
go back to reference Simpson S, Eurich D, Majumdar S, Padwal R, Tsuyuki R, Varnery J, Johnson J: A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006, doi:10.1136/bmj.38875.675486.55 Simpson S, Eurich D, Majumdar S, Padwal R, Tsuyuki R, Varnery J, Johnson J: A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006, doi:10.1136/bmj.38875.675486.55
31.
go back to reference Meichembaum D, Turk D: Facilitating treatment adherence: a practitioner's guidebook. 1987, New York: PlenumCrossRef Meichembaum D, Turk D: Facilitating treatment adherence: a practitioner's guidebook. 1987, New York: PlenumCrossRef
32.
go back to reference Lewsey J: Comparing completely and stratified randomized designs in cluster randomized trials when the stratifying factor is cluster size: a simulation study. Stat Med. 2004, 23: 897-905. 10.1002/sim.1665.CrossRefPubMed Lewsey J: Comparing completely and stratified randomized designs in cluster randomized trials when the stratifying factor is cluster size: a simulation study. Stat Med. 2004, 23: 897-905. 10.1002/sim.1665.CrossRefPubMed
33.
go back to reference McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P: The Hawthorne effect: a randomised controlled trial. BMC Health Services Research. 2009, doi:101186/1471-2288-7-30 2007 McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P: The Hawthorne effect: a randomised controlled trial. BMC Health Services Research. 2009, doi:101186/1471-2288-7-30 2007
34.
37.
go back to reference Von Korff M, Wagner E, Saunders K: A chronic disease score from automated pharmacy data. J Clin Epidmiol. 1992, 45: 197-203. 10.1016/0895-4356(92)90016-G.CrossRef Von Korff M, Wagner E, Saunders K: A chronic disease score from automated pharmacy data. J Clin Epidmiol. 1992, 45: 197-203. 10.1016/0895-4356(92)90016-G.CrossRef
Metadata
Title
A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study
Authors
Charity D Evans
Dean T Eurich
Jeff G Taylor
Alfred J Remillard
Yvonne M Shevchuk
David F Blackburn
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Trials / Issue 1/2010
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-11-76

Other articles of this Issue 1/2010

Trials 1/2010 Go to the issue